Anteo Diagnostics Ltd has released a press release.
Response to ASX Query - First commercial Ultranode order
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- First commercial Ultranode order
- FY2024 Full Year Results - Investor Presentation
- FY2024 Full Year Appendix 4E and Annual Report
- First Commercial Evaluation of AnteoBind NXT
- US$1.8m AnteoBind Purchase Agreement over 5 years
Later from AnteoTech
- $4m ARENA Grant
- AnteoTech $3.5m Placement, launch of $5m Entitlement Offer
- $5m Entitlement Offer opens
- Chair's Address to Shareholders
- Life Sciences Update
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech